B
RDY icon

Bailard’s Dr. Reddy's Laboratories RDY Stock Holding History

Bailard’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-95,150
Closed -$1.23M – 308
2015
Q3 		$1.23M Buy
95,150
+45,150
+90% +$561K 0.19% 83
2015
Q2 		$643K Buy
50,000
+25,000
+100% +$276K 0.1% 125
2015
Q1 		$260K Sell
25,000
-125,100
-83% -$1.33M 0.04% 204
2014
Q4 		$1.51M Buy
150,100
+125,000
+498% +$1.32M 0.21% 79
2014
Q3 		$264K Sell
25,100
-24,900
-50% -$234K 0.04% 192
2014
Q2 		$432K Buy
50,000
+10,000
+25% +$84.1K 0.07% 141
2014
Q1 		$351K Buy
+40,000
New +$348K 0.06% 162
2013
Q3 		– Sell
-110,000
Closed -$832K – 232
2013
Q2 		$832K Buy
+110,000
New +$803K 0.15% 116

Other funds holding RDY

Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
CBOA
Commonwealth Bank of Australia Sydney, NSW, Australia $355M AUM
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VAM
Vontobel Asset Management New York $18.1B AUM 28.09% 1-Year Est. Return
BG
BlackRock Group London, United Kingdom $210B AUM 15.5% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Bailard's RDY Position: Q4 2015 in Review

Bailard sold out of Dr. Reddy's Laboratories (RDY) in Q4 2015, closing a stake of 95,150 shares — an estimated $1.23M sold.

Bailard first reported a position in RDY in Q2 2013 and held it in 8 quarters. The position peaked at $1.51M in Q4 2014. 174 funds tracked by Wall St. Rank hold RDY as of Q4 2015.

  • Bailard reported no remaining Dr. Reddy's Laboratories position as of Q4 2015 after selling out during the quarter.
  • Bailard sold 95,150 Dr. Reddy's Laboratories shares in Q4 2015, an estimated $1.23M.
  • Bailard first reported a position in Dr. Reddy's Laboratories in Q2 2013 and held it in 8 quarters.
  • Bailard's Dr. Reddy's Laboratories position peaked at $1.51M in Q4 2014.
  • 174 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q4 2015.

Based on Bailard's 13F filing for Q4 2015, filed 10 Feb 2016.